Goldman discloses combined ~$75M stake in CAPR, SLS, and IBRX

IBRX +1.12% SLS -0.94% CAPR -13.07%

1. 1Goldman Sachs files disclosure of combined ~$75M stake in Capricor (CAPR), Cel-Sci (SLS), and ImmunityBio (IBRX)
2. 2Increased Capricor stake by 73% (1.58M shares, $38M) and Cel-Sci stake by 5.2% (585,035 shares, $8.64M)
3. 3All three biotechs approaching key milestones including FDA reviews, clinical top-line readouts, and commercialization

Source Stocktwits +1 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →